Skip to Content

SGI US Large Cap Equity C SGICX

Medalist Rating as of | See Summit Global Investment Hub
  • NAV / 1-Day Return 18.29  /  −0.76 %
  • Total Assets 205.3 Mil
  • Adj. Expense Ratio
    1.980%
  • Expense Ratio 1.980%
  • Distribution Fee Level High
  • Share Class Type Level Load
  • Category Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.01%
  • Turnover 88%

USD | NAV as of Apr 16, 2024 | 1-Day Return as of Apr 16, 2024, 12:08 AM GMT+0

Morningstar’s Analysis SGICX

Will SGICX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in SGI US Large Cap Equity C's People and Process Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings SGICX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 30.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Automatic Data Processing Inc

3.43 7.3 Mil
Industrials

Elevance Health Inc

3.13 6.6 Mil
Healthcare

Owens-Corning Inc

3.07 6.5 Mil
Industrials

Vertex Pharmaceuticals Inc

3.07 6.5 Mil
Healthcare

Colgate-Palmolive Co

2.98 6.3 Mil
Consumer Defensive

D.R. Horton Inc

2.96 6.3 Mil
Consumer Cyclical

Cardinal Health Inc

2.92 6.2 Mil
Healthcare

The Hershey Co

2.91 6.2 Mil
Consumer Defensive

United Therapeutics Corp

2.84 6.0 Mil
Healthcare

Molina Healthcare Inc

2.76 5.9 Mil
Healthcare